BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15498589)

  • 1. Virus evolution within patients increases pathogenicity.
    Iwasa Y; Michor F; Nowak MA
    J Theor Biol; 2005 Jan; 232(1):17-26. PubMed ID: 15498589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some basic properties of immune selection.
    Iwasa Y; Michor F; Nowak M
    J Theor Biol; 2004 Jul; 229(2):179-88. PubMed ID: 15207473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8+ regulatory T cells in persistent human viral infections.
    Billerbeck E; Thimme R
    Hum Immunol; 2008 Nov; 69(11):771-5. PubMed ID: 18789990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolutionary pattern of intra-host pathogen antigenic drift: effect of cross-reactivity in immune response.
    Haraguchi Y; Sasaki A
    Philos Trans R Soc Lond B Biol Sci; 1997 Jan; 352(1349):11-20. PubMed ID: 9051713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling viral and immune system dynamics.
    Perelson AS
    Nat Rev Immunol; 2002 Jan; 2(1):28-36. PubMed ID: 11905835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral reproductive strategies: How can lytic viruses be evolutionarily competitive?
    Komarova NL
    J Theor Biol; 2007 Dec; 249(4):766-84. PubMed ID: 17945261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of HVR-1 quasispecies after 1-year treatment in HIV/HCV-coinfected patients according to the pattern of response to highly active antiretroviral therapy.
    Solmone M; Girardi E; Lalle E; Abbate I; D'Arminio Monforte A; Cozzi-Lepri A; Alessandrini A; Piscopo R; Ebo F; Cosco L; Antonucci G; Ippolito G; Capobianchi MR; ;
    Antivir Ther; 2006; 11(1):87-94. PubMed ID: 16518964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunobiology of persistent blood-borne viral infections.
    Vyas GN
    Dev Biol (Basel); 2000; 102():9-17. PubMed ID: 10794086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral resistance and impact on viral replication capacity: evolution of viruses under antiviral pressure occurs in three phases.
    Nijhuis M; van Maarseveen NM; Boucher CA
    Handb Exp Pharmacol; 2009; (189):299-320. PubMed ID: 19048205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human immunodeficiency virus and its pathogenesis.
    Levy JA
    Infect Dis Clin North Am; 1988 Jun; 2(2):285-97. PubMed ID: 2974466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations between virus infection and pathogenicity in humans.
    Agut H; Huraux JM
    Dev Biol Stand; 1991; 75():211-7. PubMed ID: 1794623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective deletion mutant amplification.
    McLeod B; Burroughs N
    J Theor Biol; 2000 Oct; 206(4):449-64. PubMed ID: 11013108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The basic reproduction ratio for a model of directly transmitted infections considering the virus charge and the immunological response.
    Leite MB; Bassanezi RC; Yang HM
    IMA J Math Appl Med Biol; 2000 Mar; 17(1):15-31. PubMed ID: 10757030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of HIV on host-virus interactions during early hepatitis C virus infection.
    Danta M; Semmo N; Fabris P; Brown D; Pybus OG; Sabin CA; Bhagani S; Emery VC; Dusheiko GM; Klenerman P
    J Infect Dis; 2008 Jun; 197(11):1558-66. PubMed ID: 18419344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins.
    Adhikary D; Behrends U; Moosmann A; Witter K; Bornkamm GW; Mautner J
    J Exp Med; 2006 Apr; 203(4):995-1006. PubMed ID: 16549597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.
    Seed CR; Kiely P; Keller AJ
    Intern Med J; 2005 Oct; 35(10):592-8. PubMed ID: 16207258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproducibility and usability of chronic virus infection model using agent-based simulation; comparing with a mathematical model.
    Itakura J; Kurosaki M; Itakura Y; Maekawa S; Asahina Y; Izumi N; Enomoto N
    Biosystems; 2010 Jan; 99(1):70-8. PubMed ID: 19751799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis.
    Collenberg E; Ouedraogo T; Ganamé J; Fickenscher H; Kynast-Wolf G; Becher H; Kouyaté B; Kräusslich HG; Sangaré L; Tebit DM
    J Med Virol; 2006 May; 78(5):683-92. PubMed ID: 16555290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reciprocal transactivation between HIV-1 and other human viruses.
    White MK; Gorrill TS; Khalili K
    Virology; 2006 Aug; 352(1):1-13. PubMed ID: 16725168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral immune evasion: a masterpiece of evolution.
    Vossen MT; Westerhout EM; Söderberg-Nauclér C; Wiertz EJ
    Immunogenetics; 2002 Nov; 54(8):527-42. PubMed ID: 12439615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.